Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2021-07-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
NCT00447980
A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa
NCT00447993
REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients
NCT04276558
A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy
NCT02659098
OcuDyne System in the Treatment of AMD
NCT05091476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
-Availability of macular optical coherence tomography (OCT)
Optical coherence tomography (OCT)
Data of macular optical coherence tomography (OCT)
Controls
-Availability of macular optical coherence tomography (OCT)
Optical coherence tomography (OCT)
Data of macular optical coherence tomography (OCT)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical coherence tomography (OCT)
Data of macular optical coherence tomography (OCT)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Low vision as defined as visual acuity worse or equal to 0.05 (or 20/400) in the study eye
* Availability of macular optical coherence tomography (OCT)
* Normal ophthalmic findings
* Availability of macular optical coherence tomography (OCT)
Exclusion Criteria
* Extraocular disease affecting retinal structure such as neurodegenerative diseases
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Molecular and Clinical Ophthalmology Basel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicolas Feltgen, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Basel/Institute of Molecular and Clinical Ophthalmology Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California San Francisco, Department of Ophthalmology
San Francisco, California, United States
Bascom Palmer Eye Institute
Miami, Florida, United States
University of Pittsburgh, Department of Ophthalmology
Pittsburgh, Pennsylvania, United States
Beijing Institute of Ophthalmology
Beijing, , China
Universitätsklinikum Tübingen Augenklinik
Tübingen, , Germany
Semmelweis University, Department of Ophthalmology
Budapest, , Hungary
Oculista Ospedale Parma
Parma, , Italy
University Hospital Basel, Eye Clinic
Basel, , Switzerland
Moorfields Eye Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Stefano Gandolfi, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IOB_EyeConic_2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.